Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia; British Journal of Clinical Pharmacology; Vol. 86, iss. 9
| Parent link: | British Journal of Clinical Pharmacology Vol. 86, iss. 9.— 2020.— [P. 1827-1835] |
|---|---|
| Korporativní autor: | Национальный исследовательский Томский политехнический университет Инженерная школа неразрушающего контроля и безопасности Отделение контроля и диагностики |
| Další autoři: | Geers L. M., Pozhidaev I. V. Ivan, Ivanova S. A. Svetlana Aleksandrovna, Freydin M. B. Maksim Borisovich, Schmidt A. F. Amand, Cohen D., Boyko A. S., Paderina D. Z. Diana, Fedorenko O. Yu. Olga Yurievna, Semke A. V., Bokhan N. A. Nikolay Aleksandrovich, Wilffert B. Bob, Kosterink J. G.W. Jos, Touw D. J., Loonen A. J. M Anton |
| Shrnutí: | Title screen Hyperprolactinaemia, a common adverse effect of antipsychotic drugs, is primarily linked to blockade of dopamine D2 receptors in the pituitary gland. Certain antipsychotic drugs, such as, for example risperidone and paliperidone, are more likely to induce hyperprolactinaemia compared to others. This effect is probably caused by a relatively high blood/brain concentration ratio, a consequence of being a substrate of P‐glycoprotein. Genetic variants of P‐glycoprotein with changed functional activity might influence the potential of risperidone and paliperidone to cause hyperprolactinaemia as the altered blood/brain concentration ratio would lead to a reduced therapeutic drug level within essential brain areas making dose adaptations necessary. This increases exposure of dopamine D2 receptors within the pituitary gland. Режим доступа: по договору с организацией-держателем ресурса |
| Jazyk: | angličtina |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://doi.org/10.1111/bcpt.13173 |
| Médium: | Elektronický zdroj Kapitola |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=664042 |
Podobné jednotky
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design; Human Psychopharmacology: Clinical and Experimental; Vol. 37, iss. 3
Vydáno: (2022)
Vydáno: (2022)
Hyperprolactinemia and CYP2D6, DRD2 and HTR2C genes polymorphism in patients with schizophrenia; Physiology and Pharmacology; Vol. 21, iss. 1
Vydáno: (2017)
Vydáno: (2017)
Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia; The World Journal of Biological Psychiatry; Vol. 18, iss. 3
Vydáno: (2016)
Vydáno: (2016)
NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia; Progress in Neuro-Psychopharmacology and Biological Psychiatry; Vol. 143
Vydáno: (2025)
Vydáno: (2025)
Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression; Frontiers in Pharmacology; Vol. 10
Vydáno: (2019)
Vydáno: (2019)
Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia; Human Psychopharmacology: Clinical and Experimental; Vol. 35, iss. 4
Vydáno: (2020)
Vydáno: (2020)
Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia; The Application of Clinical Genetics; Vol. 13
Vydáno: (2020)
Vydáno: (2020)
Quantitative detection of a1-acid glycoprotein (AGP) level in blood plasma using SERS and CNN transfer learning approach; Sensors and Actuators B: Chemical; Vol. 367
Vydáno: (2022)
Vydáno: (2022)
No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic‐induced tardive dyskinesia; Human Psychopharmacology: Clinical and Experimental; Vol. 34, iss. 1
Vydáno: (2019)
Vydáno: (2019)
A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia; BMC Medical Genetics; Vol. 20
Vydáno: (2019)
Vydáno: (2019)
Neurobiological mechanisms associated with antipsychotic drug-induced dystonia; Journal of Psychopharmacology; Vol. 35, iss. 1
Autor: Loonen A. J. M. Anton
Vydáno: (2021)
Autor: Loonen A. J. M. Anton
Vydáno: (2021)
Ассоциация полиморфизмов гена СОМТ с болезнью Паркинсона; Бюллетень сибирской медицины; Т. 16, № 3
Vydáno: (2017)
Vydáno: (2017)
Post-Transcriptional Gene Regulation
Vydáno: (2022)
Vydáno: (2022)
Gene Expression Analysis Methods and Protocols /
Vydáno: (2025)
Vydáno: (2025)
Cell-Free Gene Expression Methods and Protocols /
Vydáno: (2022)
Vydáno: (2022)
Association of PIP4K2A Polymorphisms with Alcohol Use Disorder; Genes; Vol. 12, iss. 10
Vydáno: (2021)
Vydáno: (2021)
Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome; Frontiers in Psychiatry; Vol. 10
Vydáno: (2019)
Vydáno: (2019)
Salts of barbituric and 2-thiobarbituric acids with imidazole: polymorphism, supramolecular structure, thermal stability and water solubility; New Journal of Chemistry; Vol. 47, iss. 47
Vydáno: (2023)
Vydáno: (2023)
SIRT1 Allele Frequencies in Depressed Patients of European Descent in Russia; Frontiers in Genetics; Vol. 9
Vydáno: (2019)
Vydáno: (2019)
A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia; Progress in Neuro-Psychopharmacology and Biological Psychiatry; Vol. 105
Vydáno: (2021)
Vydáno: (2021)
Experimental Simulation of LDPE Structure Polymorphism Occurrence Reasons; Journal of Chemistry and Chemical Engineering; Vol. 2, № 1
Vydáno: (2015)
Vydáno: (2015)
Genetic polymorphisms of PIP5K2A and course of schizophrenia; BMC Medical Genetics; Vol. 21
Vydáno: (2020)
Vydáno: (2020)
Deadenylation Methods and Protocols /
Vydáno: (2024)
Vydáno: (2024)
Transcription Factor Regulatory Networks
Vydáno: (2023)
Vydáno: (2023)
Efficient gene editing via non-viral delivery of CRISPR-Cas9 system using polymeric and hybrid microcarriers; Nanomedicine: Nanotechnology, Biology and Medicine; Vol. 14, iss. 1
Vydáno: (2018)
Vydáno: (2018)
Histone Methyltransferases Methods and Protocols /
Vydáno: (2022)
Vydáno: (2022)
Cytotoxic, Genotoxic, and Polymorphism Effects on Vanilla planifolia Jacks ex Andrews after Long-Term Exposure to Argovit® Silver Nanoparticles; Nanomaterials; Vol. 8, iss. 10
Vydáno: (2018)
Vydáno: (2018)
Layer-by-Layer technique as a versatile tool for gene delivery applications; Expert Opinion on Drug Delivery; Vol. XX, iss. X
Vydáno: (2021)
Vydáno: (2021)
Silver nanoparticle treatment partially restores antibiotic activity by reducing the number of isolates with antibiotic-resistant genes in cows with mastitis; Microbial Pathogenesis; Vol. 207
Vydáno: (2025)
Vydáno: (2025)
The Integrated Stress Response Methods and Protocols /
Vydáno: (2022)
Vydáno: (2022)
Gene expression regulation and secretory activity of mesenchymal stem cells upon in vitro contact with microarc calcium phosphate coating; International Journal of Molecular Sciences; Vol. 21, iss. 20
Vydáno: (2020)
Vydáno: (2020)
Prolactin gene polymorphism (- 1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics; Schizophrenia Research; Vol. 182
Vydáno: (2017)
Vydáno: (2017)
SERS and advanced chemometrics – Utilization of Siamese neural network for picomolar identification of beta-lactam antibiotics resistance gene fragmen; Analytica Chimica Acta; Vol. 1192
Vydáno: (2022)
Vydáno: (2022)
Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia; Heliyon; Vol. 5, iss. 7
Vydáno: (2019)
Vydáno: (2019)
RNA Structure Prediction
Vydáno: (2023)
Vydáno: (2023)
Lentiviral gene delivery to plasmolipin-expressing cells using Mus caroli endogenous retrovirus envelope protein; Biochimie; Vol. 142
Vydáno: (2017)
Vydáno: (2017)
Mesenchymal Stem Cells Engineering: Microcapsules-Assisted Gene Transfection and Magnetic Cell Separation; ACS Biomaterials Science and Engineering; Vol. 10, iss. 3
Vydáno: (2017)
Vydáno: (2017)
Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors; The World Journal of Biological Psychiatry; Latest Articles
Vydáno: (2018)
Vydáno: (2018)
Transcriptome Data Analysis
Vydáno: (2024)
Vydáno: (2024)
Карбонаты кальция в холелитах; Известия Томского политехнического университета [Известия ТПУ]; Т. 326, № 1 : Ресурсы планеты
Autor: Машина Е. В. Екатерина Валерьевна
Vydáno: (2015)
Autor: Машина Е. В. Екатерина Валерьевна
Vydáno: (2015)
Podobné jednotky
-
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design; Human Psychopharmacology: Clinical and Experimental; Vol. 37, iss. 3
Vydáno: (2022) -
Hyperprolactinemia and CYP2D6, DRD2 and HTR2C genes polymorphism in patients with schizophrenia; Physiology and Pharmacology; Vol. 21, iss. 1
Vydáno: (2017) -
Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia; The World Journal of Biological Psychiatry; Vol. 18, iss. 3
Vydáno: (2016) -
NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia; Progress in Neuro-Psychopharmacology and Biological Psychiatry; Vol. 143
Vydáno: (2025) -
Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression; Frontiers in Pharmacology; Vol. 10
Vydáno: (2019)